Ticker · CUSIP 49721T507

KPRX

KIORA PHARMACEUTICALS INC
···Share
Holders (tracked)
2
Combined shares
43,581
Combined value
$85.9K
Last close
$2.52
Quarter
2025Q4
Price · 1Y$2.52-0.27 (-9.68%)H $3.90 · L $1.80 · Avg Vol 261K
Position opened
$2.00$2.50$3.00$3.50$4.00VolJul 25Oct 25Jan 26Apr 26
Tracked holders · last 8 quarters
-1 vs previous quarter over the last 5.
212024Q22025Q4
Price is +27.9% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

5 events
  1. −22,192 shares · 2025Q4
    Position
  2. −11,984 shares · 2025Q4
    Position
  3. +8,800 shares · 2025Q4
    Position
  4. +11,984 shares · 2025Q3
    Position
  5. +12,400 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of KPRX…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
Renaissance Technologies2025Q3$2.44+3.1%$53K
Ken Griffin (Citadel Advisors)2024Q3$3.07-18.0%$56K

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions0
Added to1
Trimmed1
Exited1

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2024Q2
1
$7K
2024Q3
1
$37K
2025Q1
1
$80K
2025Q3
3
$193K
2025Q4
2
$86K

Who owns KPRX

2 super-investors · 2025Q4
Tracked stake
43.6K
shares
Combined value
$86K
% of shares outstanding
shares-out unknown
Quarter action mix
Added1Trim1
#ManagerSharesValue
1Ken Griffin
Citadel Advisors
22.4K$44K
2Renaissance Technologies21.2K$42K

Recent moves

6 transactions
Embed this chart
Paste this iframe anywhere to embed the live KPRX chart.
<iframe src="https://openstocks.me/embed/stocks/KPRX" width="100%" height="480" frameborder="0" loading="lazy" title="KPRX chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>
Explore related topics